Substance use disorders during the COVID-19 pandemic: looking for new innovative approaches

Background and aim: The destructive impact of the still ongoing COVID-19 pandemic on those struggling with substance use disorders (SUD) stems from the daunting challenges which SUD patients experience in terms of coping with their condition and receiving care in a timely fashion. Methods: Patients struggling with addiction are at particularly high risk, due to the underlying vulnerabilities in their conditions and the stigmatization they often suffer. New Psychoactive Substances stand out as a critical area of concern. The authors have conducted a broad-ranging search to assess the impact of SUDs, along with their related mental, physical, and behavioral symptoms, against the backdrop of the COVID-19, taking into account how drug trafficking and consumption trends have evolved as the emergency draws out, and the cyberspace comes to play an ever-bigger role. Results: Given that roughly 1.5%-5% of the global burden of disease can be ascribed to alcohol abuse and substance addiction, the role of pandemic-related potential contributing factors in the exacerbation and relapse of SUDs and behavioral addiction cannot be discounted and needs targeted measures tailored to the special needs of SUD patients. Escalating environmental stressors stemming from abnormal circumstances can undermine recovery efforts and threaten the very survival of countless SUD patients, increasing the likelihood of relapsing for those in recovery. Conclusions: Policymakers and legislators have not yet put in place targeted measures and adjustments in the health care delivery mechanisms in order to countervail the pandemic impact on SUD sufferers, and the ever-evolving patterns of use and trafficking. (www.actabiomedica.it)

[1]  N. Scherbaum,et al.  COVID-19 Pandemic Impact on Substance Misuse: A Social Media Listening, Mixed Method Analysis , 2021, Brain sciences.

[2]  S. Boujraf,et al.  The Impact of Stigma on Treatment Services for People With Substance Use Disorders During the COVID-19 Pandemic—Perspectives of NECPAM Members , 2021, Frontiers in Psychiatry.

[3]  J. Cousijn,et al.  For better or for worse? A pre-post exploration of the impact of the COVID-19 lockdown on cannabis users. , 2021, Addiction.

[4]  C. Gambelunghe,et al.  Changes in Drug Use Patterns during the COVID-19 Pandemic in Italy: Monitoring a Vulnerable Group by Hair Analysis , 2020, International journal of environmental research and public health.

[5]  F. Schifano,et al.  Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach , 2021, Frontiers in Psychiatry.

[6]  W. Hall,et al.  Cannabis and COVID-19: Reasons for Concern , 2020, Frontiers in Psychiatry.

[7]  M. Torrens,et al.  Editorial: New Trends of Substance Abuse: Looking for New Psychotropic Effects of Chem Sex Drugs, Cognitive Enhancers, and New Psychoactive Substances , 2020, Frontiers in Psychiatry.

[8]  A. Dopp,et al.  Combatting the Stigma of Addiction - The Need for a Comprehensive Health System Approach. , 2020, NAM perspectives.

[9]  G. Ricci,et al.  Consequences of COVID-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances , 2020, Frontiers in Psychiatry.

[10]  M. Camacho-Rivera,et al.  The COVID-19 cannabis health study: Results from an epidemiologic assessment of adults who use cannabis for medicinal reasons in the United States , 2020, Journal of addictive diseases.

[11]  E. Onaivi,et al.  Cannabis for COVID-19: can cannabinoids quell the cytokine storm? , 2020, Future science OA.

[12]  S. Dubey,et al.  COVID-19 and addiction , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[13]  F. Pechansky,et al.  The COVID-19 pandemic and its impact on substance use: Implications for prevention and treatment , 2020, Psychiatry Research.

[14]  N. Volkow Stigma and the Toll of Addiction. , 2020, The New England journal of medicine.

[15]  S. Pichini,et al.  Development and validation of fast UHPLC-MS/MS screening method for 87 NPS and 32 other drugs of abuse in hair and nails: application to real cases , 2020, Analytical and Bioanalytical Chemistry.

[16]  R. Pacifici,et al.  Δ9-Tetrahydrocannabinol and Cannabidiol Time Courses in the Sera of "Light Cannabis" Smokers: Discriminating Light Cannabis Use from Illegal and Medical Cannabis Use. , 2020, Therapeutic drug monitoring.

[17]  R. Bruno,et al.  New psychoactive substances: challenges for drug surveillance, control, and public health responses , 2019, The Lancet.

[18]  S. Zaami New psychoactive substances: concerted efforts and common legislative answers for stemming a growing health hazard. , 2019, European review for medical and pharmacological sciences.

[19]  R. Pacifici,et al.  The value of toxicological and forensic analyses in the global challenge to health risks caused by new psychoactive substances. , 2019, European review for medical and pharmacological sciences.

[20]  A. Tagliabracci,et al.  Editorial: The Challenge Posed by New Synthetic Opioids: Pharmacology and Toxicology , 2019, Front. Pharmacol..

[21]  T. Rosado,et al.  Novel synthetic opioids – toxicological aspects and analysis , 2019, Forensic sciences research.

[22]  Jacek Kopec,et al.  The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2018, The lancet. Psychiatry.

[23]  N. M. di Luca,et al.  Medical use of cannabis: Italian and European legislation. , 2018, European review for medical and pharmacological sciences.

[24]  S. Pichini,et al.  Correlation between Blood and Oral Fluid Psychoactive Drug Concentrations and Cognitive Impairment in Driving under the Influence of Drugs , 2017, Current neuropharmacology.

[25]  R. Pacifici,et al.  European Drug Users at Risk from Illicit Fentanyls Mix , 2017, Front. Pharmacol..

[26]  Justin Arnold,et al.  Novel Psychoactive Substances and Trends of Abuse , 2017, Critical care nursing quarterly.

[27]  F. Indorato,et al.  The pathogenetic role of adulterants in 5 cases of drug addicts with a fatal outcome. , 2013, Forensic science international.